|
|
Article: Neurally Mediated Hypotension in Chronic Fatigue Syndrome.
- Article from:
- Clinical Cardiology Alert
- Article date:
- March 1, 2001
CopyrightCOPYRIGHT 2001 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Neurally Mediated Hypotension in Chronic Fatigue Syndrome
Abstract & Commentary
Synopsis: The therapy of neurally mediated hypotension with fludrocortisone does not provide reliable symptomatic improvement in patients with chronic fatigue syndrome.
Source: Rowe PC, et al. JAMA 2001;285:52-59.
Rowe and colleagues conducted a study of the effect of fludrocortisone acetate in patients with neurally mediated hypotension in the setting of chronic fatigue syndrome. Patients who met Center For Disease Control (CDC) criteria for chronic fatigue syndrome were screened for other reversible causes of fatigue and had four or more of the following ...